medlinkPomalidomide/medlink, a cancer medication, has been revealed in a clinical trial to be safe and efficacious in treating hereditary...

medlinkPomalidomide/medlink, a cancer medication, has been revealed in a clinical trial to be safe and efficacious in treating hereditary...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a...

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder.

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder.

WEDNESDAY, Sept. 25, 2024 -- For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields...

MONDAY, Sept. 23, 2024 -- 'Before medically advised' (BMA) discharge from the hospital is associated with an increased risk for subsequent drug...

FRIDAY, Sept. 27, 2024 -- For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and...

MONDAY, Sept. 23, 2024 -- For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes,...

TUESDAY, Sept. 24, 2024 -- Metal exposure from environmental pollution is associated with the progression of atherosclerosis, according to a study...